住院患者糖尿病与高血糖的管理
本文综述住院糖尿病患者及非糖尿病患者高血糖的管理策略。高血糖与住院患者发病率、死亡率和医疗费用显著增加相关,专业学会推荐胰岛素治疗为住院药物管理基石,危重症首选静脉胰岛素。非重症监护环境中多种胰岛素方案并存但荟萃分析未明确支持某一策略;部分国家住院2型糖尿病患者继续口服降糖药常见,临床试验提示非胰岛素药物单用或联合基础胰岛素可在特定人群实现血糖控制。糖尿病技术进展(持续葡萄糖监测、自动胰岛素输注)正推动住院护理变革,COVID-19疫情期间远程住院糖尿病管理等转变也需进一步研究评估。
要点
- 危重症住院患者高血糖首选静脉胰岛素治疗
- 非重症住院患者多种胰岛素方案并存,荟萃分析未明确支持某一策略
- 特定2型糖尿病住院患者可考虑非胰岛素药物单用或联合基础胰岛素
核心结论
- 住院患者高血糖与发病率、死亡率和医疗费用显著增加相关
- 专业学会推荐胰岛素治疗为住院药物管理基石
- 危重症首选静脉胰岛素治疗
研究设计与样本
- 综述类文章,检索范围未在摘要中报告
主要发现
- 非重症监护环境中多种胰岛素方案被提出,但比较不同方案的荟萃分析未明确支持某一策略的获益
- 临床指南推荐住院期间停用口服降糖药,但部分国家住院2型糖尿病患者继续使用口服降糖药较常见
- 临床试验提示非胰岛素药物单用或联合基础胰岛素可在特定人群实现适当血糖控制
- 糖尿病技术(持续葡萄糖监测、自动胰岛素输注)正被探索用于住院护理
- COVID-19疫情期间出现远程住院糖尿病管理等护理转变,需研究评估其效果
临床怎么用
- 危重症住院高血糖采用静脉胰岛素治疗
- 非重症住院患者胰岛素方案选择需个体化,因荟萃分析未明确支持某一策略
- 特定2型糖尿病住院患者可考虑非胰岛素药物单用或联合基础胰岛素控制血糖
局限性
- 摘要未报告综述的检索范围与纳入标准
- 不同胰岛素方案的比较缺乏明确获益证据
- 住院使用糖尿病新技术及远程管理 adaptations 的效果尚待研究评估
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyperglycaemia in people with and without diabetes admitted to the hospital is associated with a substantial increase in morbidity, mortality, and health-care costs. Professional societies have recommended insulin therapy as the cornerstone of inpatient pharmacological management. Intravenous insulin therapy is the treatment of choice in the critical care setting. In non-intensive care settings, several insulin protocols have been proposed to manage patients with hyperglycaemia; however, meta-analyses comparing different treatment regimens have not clearly endorsed the benefits of any particular strategy. Clinical guidelines recommend stopping oral antidiabetes drugs during hospitalisation; however, in some countries continuation of oral antidiabetes drugs is commonplace in some patients with type 2 diabetes admitted to hospital, and findings from clinical trials have suggested that non-insulin drugs, alone or in combination with basal insulin, can be used to achieve appropriate glycaemic control in selected populations. Advances in diabetes technology are revolutionising day-to-day diabetes care and work is ongoing to implement these technologies (ie, continuous glucose monitoring, automated insulin delivery) for inpatient care. Additionally, transformations in care have occurred during the COVID-19 pandemic, including the use of remote inpatient diabetes management-research is needed to assess the effects of such adaptations.
引用
- Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021. PMID: 33515493. doi:10.1016/S2213-8587(20)30381-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。